We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The JV fast tracks Strides’ entry into China, the second-largest pharmaceutical market in the World offering a $137 billion (IQVIA) market opportunity.
The Drugs Controller General (India) has granted permission to an Indian firm to conduct Phase-I clinical trial, in pursuance to its application to the DCG(I) on a Zika virus vaccine, the government has said.